Ticagrelor Increases SIRT1 and HES1 mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease

Ticagrelor is a powerful P2Y(12) inhibitor with pleiotropic effects in the cardiovascular system. Consistently, we have reported that in patients with stable coronary artery disease (CAD) and concomitant chronic obstructive pulmonary disease (COPD) who underwent percutaneous coronary intervention (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Aquila, Giorgio, Vieceli Dalla Sega, Francesco, Marracino, Luisa, Pavasini, Rita, Cardelli, Laura Sofia, Piredda, Anna, Scoccia, Alessandra, Martino, Valeria, Fortini, Francesca, Bononi, Ilaria, Martini, Fernanda, Manfrini, Marco, Pannuti, Antonio, Ferrari, Roberto, Rizzo, Paola, Campo, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084534/
https://www.ncbi.nlm.nih.gov/pubmed/32106619
http://dx.doi.org/10.3390/ijms21051576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084534/
https://www.ncbi.nlm.nih.gov/pubmed/32106619
http://dx.doi.org/10.3390/ijms21051576

Ejemplares similares